ARS Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (SPRY)
CUSIP: 82835W108
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 99,255,583
- Total 13F shares
- 62,590,275
- Share change
- +2,642,192
- Total reported value
- $533,041,807
- Put/Call ratio
- 6.1%
- Price per share
- $8.51
- Number of holders
- 112
- Value change
- +$21,909,612
- Number of buys
- 65
- Number of sells
- 45
Quarterly Holders Quick Answers
What is CUSIP 82835W108?
CUSIP 82835W108 identifies SPRY - ARS Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 82835W108:
Top shareholders of SPRY - ARS Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
11%
|
11,077,927
|
$113,216,414 | — | 31 Mar 2024 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
11%
|
10,860,977
|
$110,999,185 | — | 31 Mar 2024 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
9.3%
|
9,240,887
|
$94,441,865 | — | 31 Mar 2024 | |
| SR ONE CAPITAL MANAGEMENT, LP |
13F
|
Company |
4%
|
4,012,903
|
$41,011,869 | — | 31 Mar 2024 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
3%
|
2,950,963
|
$30,158,842 | — | 31 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
2.9%
|
2,886,455
|
$29,499,570 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
2.7%
|
2,658,239
|
$27,167,202 | — | 31 Mar 2024 | |
| K2 PRINCIPAL FUND, L.P. |
13F
|
Company |
2.2%
|
2,219,131
|
$22,679,519 | — | 31 Mar 2024 | |
| Nextech Invest Ltd. |
13F
|
Company |
1.9%
|
1,910,029
|
$19,520,496 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
1.6%
|
1,604,550
|
$16,398,501 | — | 31 Mar 2024 | |
| FMR LLC |
13F
|
Company |
1.1%
|
1,084,922
|
$11,087,903 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.88%
|
876,671
|
$8,961,353 | — | 31 Mar 2024 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
0.87%
|
867,319
|
$8,864,000 | — | 31 Mar 2024 | |
| Rubric Capital Management LP |
13F
|
Company |
0.64%
|
639,203
|
$6,532,655 | — | 31 Mar 2024 | |
| ROYCE & ASSOCIATES LP |
13F
|
Company |
0.56%
|
558,700
|
$5,709,914 | — | 31 Mar 2024 | |
| Sio Capital Management, LLC |
13F
|
Company |
0.54%
|
536,163
|
$5,479,586 | — | 31 Mar 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.47%
|
462,716
|
$4,728,957 | — | 31 Mar 2024 | |
| Invesco Ltd. |
13F
|
Company |
0.41%
|
411,372
|
$4,204,222 | — | 31 Mar 2024 | |
| Woodline Partners LP |
13F
|
Company |
0.4%
|
401,788
|
$4,106,273 | — | 31 Mar 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.35%
|
345,295
|
$3,528,915 | — | 31 Mar 2024 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.28%
|
277,706
|
$2,838,155 | — | 31 Mar 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.28%
|
275,289
|
$2,813,454 | — | 31 Mar 2024 | |
| ClariVest Asset Management LLC |
13F
|
Company |
0.28%
|
272,956
|
$2,789,610 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.26%
|
262,109
|
$2,678,755 | — | 31 Mar 2024 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.24%
|
239,194
|
$2,444,563 | — | 31 Mar 2024 | |
| SECTORAL ASSET MANAGEMENT INC |
13F
|
Company |
0.21%
|
204,437
|
$2,089,346 | — | 31 Mar 2024 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.13%
|
128,889
|
$1,317,000 | — | 31 Mar 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.11%
|
113,205
|
$1,156,955 | — | 31 Mar 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.11%
|
112,065
|
$1,145,304 | — | 31 Mar 2024 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.11%
|
111,559
|
$1,140,133 | — | 31 Mar 2024 | |
| UBS Group AG |
13F
|
Company |
0.11%
|
104,441
|
$1,067,387 | — | 31 Mar 2024 | |
| AWM Investment Company, Inc. |
13F
|
Company |
0.1%
|
100,000
|
$1,022,000 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.1%
|
97,953
|
$1,001,080 | — | 31 Mar 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.1%
|
97,595
|
$997,421 | — | 31 Mar 2024 | |
| CITIGROUP INC |
13F
|
Company |
0.1%
|
97,462
|
$996,062 | — | 31 Mar 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.09%
|
92,328
|
$943,592 | — | 31 Mar 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.08%
|
81,579
|
$833,737 | — | 31 Mar 2024 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.08%
|
81,042
|
$828,249 | — | 31 Mar 2024 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.08%
|
80,845
|
$826,236 | — | 31 Mar 2024 | |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP |
13F
|
Company |
0.08%
|
80,798
|
$826,000 | — | 31 Mar 2024 | |
| CAPSTONE INVESTMENT ADVISORS, LLC |
13F
|
Company |
0.07%
|
72,322
|
$739,131 | — | 31 Mar 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.07%
|
69,891
|
$714,289 | — | 31 Mar 2024 | |
| ALPS ADVISORS INC |
13F
|
Company |
0.07%
|
67,708
|
$691,976 | — | 31 Mar 2024 | |
| Swiss National Bank |
13F
|
Company |
0.07%
|
66,000
|
$674,520 | — | 31 Mar 2024 | |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC |
13F
|
Company |
0.06%
|
63,808
|
$652,118 | — | 31 Mar 2024 | |
| FAS Wealth Partners, Inc. |
13F
|
Company |
0.06%
|
60,470
|
$618,004 | — | 31 Mar 2024 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.06%
|
59,170
|
$604,717 | — | 31 Mar 2024 | |
| LEVIN CAPITAL STRATEGIES, L.P. |
13F
|
Company |
0.06%
|
55,250
|
$564,655 | — | 31 Mar 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.05%
|
50,183
|
$512,870 | — | 31 Mar 2024 | |
| STATE OF WISCONSIN INVESTMENT BOARD |
13F
|
Company |
0.04%
|
41,425
|
$423,364 | — | 31 Mar 2024 |
Institutional Holders of ARS Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (SPRY) as of Q2 2024
As of 30 Jun 2024,
ARS Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (SPRY) was held by
112 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
62,590,275 shares.
The largest 10 holders included
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), RA CAPITAL MANAGEMENT, L.P., ORBIMED ADVISORS LLC, BlackRock Inc., SR One Capital Management, LP, VANGUARD GROUP INC, FRANKLIN RESOURCES INC, K2 PRINCIPAL FUND, L.P., Nextech Invest Ltd., and STATE STREET CORP.
This page lists
112
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
113
Q2 2024 holders
112
Holder diff
-1
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.